Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($) $ in Thousands	Total	Stock Issuance in Connection with Emergence	Stock Issuance for Equity Rights Offering	Issuance of new common stock for the Equity Rights Offering backstop commitment	Issuance of new common stock for Bitmain obligation	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Contingently Redeemable Convertible Preferred Stock	Contingently Redeemable Convertible Preferred Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Stock Issuance in Connection with Emergence	Common Stock Stock Issuance for Equity Rights Offering	Common Stock Issuance of new common stock for the Equity Rights Offering backstop commitment	Common Stock Issuance of new common stock for Bitmain obligation	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-In Capital	Additional Paid-In Capital Stock Issuance in Connection with Emergence	Additional Paid-In Capital Stock Issuance for Equity Rights Offering	Additional Paid-In Capital Issuance of new common stock for the Equity Rights Offering backstop commitment	Additional Paid-In Capital Issuance of new common stock for Bitmain obligation	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021								10,826,000
Beginning balance at Dec. 31, 2021								$ 44,476
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of contingently redeemable preferred stock to common stock (in shares)								(10,826,000)
Conversion of contingently redeemable preferred stock to common stock								$ (44,476)
Ending balances (in shares) at Dec. 31, 2022								0
Ending balance at Dec. 31, 2022								$ 0
Beginning balance (in shares) at Dec. 31, 2021										271,576,000
Beginning balance at Dec. 31, 2021	$ 1,341,210									$ 27						$ 1,379,581						$ (27,432)			$ (10,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,146,318)																					(2,146,318)
Other comprehensive income, net of income taxes	10,966																								10,966
Stock-based compensation	182,894															182,894
Exercise of stock options (in shares)										1,321,000
Exercise of stock options	3,846															3,846
Restricted stock awards issued, net of tax withholding obligations (in shares)										43,762,000
Restricted stock awards issued, net of shares withheld for tax withholding obligations	(31,646)									$ 4						(31,650)
Restricted stock awards forfeited (in shares)										(2,456,000)
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	(16,600)
Ending balance (in shares) at Dec. 31, 2022										375,225,000
Ending balance at Dec. 31, 2022	$ (409,346)									$ 36						1,764,368						(2,173,750)			0
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2023-08 [Member]
Ending balances (in shares) at Dec. 31, 2023								0	0
Ending balance at Dec. 31, 2023								$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (246,487)																					(246,487)
Other comprehensive income, net of income taxes	0
Stock-based compensation	58,892															58,892
Exercise of stock options (in shares)										3,000
Restricted stock awards issued, net of tax withholding obligations (in shares)										12,046,000
Restricted stock awards forfeited (in shares)										(391,000)
Exercise of convertible notes (in shares)										197,000
Exercise of convertible notes	1,574															1,574
Cashless exercise of warrants (in shares)										3,001,000
Issuances of common stock - equity line of credit (in shares)										13,355,000
Issuances of common stock - equity line of credit	21,201									$ 1						21,200
Conversion of contingently redeemable preferred stock to common stock (in shares)										10,826,000
Conversion of contingently redeemable preferred stock to common stock	44,476									$ 1						44,475
Issuances of common stock - Merger with XPDI (in shares)										30,778,000
Issuances of common stock - Merger with XPDI	163,459									$ 3						163,456
Issuances of common stock - financing transaction fees (in shares)										1,285,000
Issuances of common stock - financing transaction fees	2,960															2,960
Issuances of common stock - vendor settlement (in shares)										1,580,000
Issuances of common stock - vendor settlement	12,674															12,674
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	$ (16,642)															(16,642)
Ending balance (in shares) at Dec. 31, 2023	386,883,000									386,883,000					386,883,000
Ending balance at Dec. 31, 2023	$ (596,941)					$ 24	$ (596,917)			$ 36					$ 36	1,823,260					$ 1,823,260	(2,420,237)	$ 24	$ (2,420,213)	0	$ 0
Ending balances (in shares) at Dec. 31, 2024								0
Ending balance at Dec. 31, 2024								$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,315,005)																					(1,315,005)
Other comprehensive income, net of income taxes	0
Stock-based compensation	52,411															52,411
Cancellation of common stock in connection with emergence (in shares)										(386,883,000)
Cancellation of common stock in connection with emergence	0									$ (36)						36
Issuance of new common stock (in shares)											152,576,000	15,649,000	2,111,000	10,735,000
Issuance of new common stock		$ 296,895	$ 55,000	$ 5,475	$ 27,839						$ 2						$ 296,893	$ 55,000	$ 5,475	$ 27,839
Conversion premium on the issuance of the New Secured Convertible Notes	33,202															33,202
Issuance of warrants	$ (345,856)															(345,856)
Exercise of stock options (in shares)	0
Exercise of stock options	$ 9															9
Restricted stock awards issued, net of tax withholding obligations (in shares)										4,543,000
Restricted stock awards issued, net of shares withheld for tax withholding obligations	(3,393)															(3,393)
Restricted stock awards forfeited (in shares)										(40,000)
Exercise of warrants (in shares)										61,565,000
Exercise of warrants	704,711									$ 1						704,710
Conversion of contingently redeemable preferred stock to common stock (in shares)										44,585,000
Conversion of contingently redeemable preferred stock to common stock	261,772															261,772
Issuance of new common stock for PIK interest (in shares)										882,000
Issuance of new common stock for PIK interest	$ 3,677															3,677
Ending balance (in shares) at Dec. 31, 2024	292,606,000									292,606,000
Ending balance at Dec. 31, 2024	$ (820,180)									$ 3						$ 2,915,035						$ (3,735,218)			$ 0